1
Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.
Species | Human |
Cat.No | ABC-H0014X |
Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Product Category | Primary Cells |
Size/Quantity | 1 vial |
Cell Type | Osteoclast |
Shipping Info | Dry Ice |
Growth Conditions | 37 ℃, 5% CO2 |
Disease | Normal |
Biosafety Level | 1 |
Storage | Liquid Nitrogen |
Product Type | Blood Products |
Human Osteoclast Precursor Cells (OCPs) are primary cells derived from the monocyte/macrophage lineage of human peripheral blood, bone marrow, or umbilical cord blood. These cells are precursors to multinucleated osteoclasts and are implicated in bone-resorptive diseases such as osteoporosis, rheumatoid arthritis, and multiple myeloma. Following isolation, they are cryopreserved and typically not passaged due to their limited proliferative capacity. OCPs exhibit monocyte-like morphology. Functionally, OCPs express surface markers including CD14, CD11b, CD115, and RANK, with CD16+ subsets showing heightened osteoclastogenic potential in inflammatory conditions. Their differentiation is RANKL-dependent, making them powerful models for studying bone metabolism disorders.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
Human Osteoclast Precursor Cells find versatile applications, notably in high-throughput studies targeting osteoporosis, bone resorption, and related diseases. They offer insights into environmental impacts on osteoclast formation and pathogenic derivation, while also enabling exploration of regulators like chemokines and M-CSF influencing osteoclast precursor cell recruitment to bone. Enhanced comprehension of OCPs’ nature, heterogeneity, and recruitment pathways holds promise for targeted therapies addressing osteoclast-specific concerns.